Dallas, TX (PRWEB) October 9, 2009
The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.
The Mulligan Law Firm is currently investigating injury claims involving Avandia's possible role in heart attacks and heart disease. Individuals who have potentially been injured after taking Avandia should consult with a legal professional immediately. Contact Eric Gruenwald, Lawyer/Attorney at (866) 529-0001, Ext. 245.
The New England Journal of Medicine published an article in which it was estimated that Avandia could increase the risk of heart attack by 43 percent and heart disease by 64 percent. On the strength of this article, the FDA issued its toughest safety warning concerning the risks of Avandia in May of 2007.
"Despite existing warnings, these drugs were being prescribed to patients with significant heart failure." -- From a written statement accompanying the F.D.A. decision to issue the safety warning on Avandia in 2007.
The November 24, 2008 issue of Archives of Internal Medicine published a paper that studied almost 30,000 diabetic patients over the age of 65. 49.7 percent of these patients had been prescribed Avandia; 50.3 percent, another popular drug used for treatment of type 2 diabetes, Actos®. 1,869 of the patients were dead a year later, and the study showed that in patients who had been prescribed Avandia, the rate of death was 15 percent higher than in those prescribed Actos.
The Mulligan Law Firm takes all cases on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.
Avandia (Rosiglitazone) is prescribed to people with type 2 (non-insulin dependent) diabetes; taken by mouth, it helps to control blood sugar levels by making the body more sensitive to the action of insulin.
It has been sold in the United States since 1999, when it was approved by the Food and Drug Administration. Avandia was heavily marketed and quickly became one of the biggest selling products manufactured by GlaxoSmithKline, a major pharmaceutical company based in London. The total sales of Avandia were $3.4 billion in 2006.
Always consult with your physician before you stop taking any medications, including Avandia.
# # #